Light: Science & Applications (Apr 2022)
A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-II fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma
Abstract
Nd3+-doped YVO4 nanotheranostic agent with blood-brain-barrier permeability could achieve NIR-II imaging/MRI and efficient SDT of orthotopic gliomas.